Soluble suppression of tumorigenicity 2 associated with microvascular obstruction in patients with ST-segment elevation myocardial infarction
Abstract Background Microvascular obstruction (MVO) develops in approximately 50% of patients with ST-segment elevation myocardial infarction (STEMI) after undergoing percutaneous coronary intervention (PCI). MVO is strongly linked to inflammation, myocardial fibrosis, and adverse clinical outcomes....
Sparad:
| Huvudupphov: | , , , , , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
BMC
2024-11-01
|
| Serie: | BMC Cardiovascular Disorders |
| Ämnen: | |
| Länkar: | https://doi.org/10.1186/s12872-024-04364-2 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|